Syntheses of human TLR8-specific small-molecule agonists

Mallesh Beesu; Hari Prasad Kokatla; Sunil A. David

doi:10.1007/978-1-4939-6445-1_3

Syntheses of human TLR8-specific small-molecule agonists

Mallesh Beesu, Hari Prasad Kokatla, Sunil A. David

Medicinal Chemistry

Research output: Chapter in Book/Report/Conference proceeding › Chapter

4 Scopus citations

Abstract

Human toll-like receptor (hTLR)-8 is expressed in myeloid dendritic cells, monocytes, and monocytederived dendritic cells. Engagement by TLR8 agonists evokes a distinct cytokine profile which favors the development of type 1 helper T cells. Focused exploration of structure-activity relationships in the imidazoquinolines has led to the identification of several novel human TLR8-specific agonists. The synthetic procedures for best-in-class analogues encompassing four chemotypes are described.

Original language	English (US)
Title of host publication	Methods in Molecular Biology
Publisher	Humana Press Inc.
Pages	29-44
Number of pages	16
DOIs	https://doi.org/10.1007/978-1-4939-6445-1_3
State	Published - 2017

Publication series

Name	Methods in Molecular Biology
Volume	1494
ISSN (Print)	1064-3745

Bibliographical note

Funding Information:
This work was supported by NIH/NIAID contracts HSN272200900033C and HHSN272201400056C.

Publisher Copyright:
© Springer Science+Business Media New York 2017.

Keywords

Innate immunity
TLR8
TLR8 agonists
Vaccine adjuvants

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1007/978-1-4939-6445-1_3

Find It

Find It at U of M Libraries

Cite this

@inbook{389e82ed0c0548c49c8f330e07fd1e2d,

title = "Syntheses of human TLR8-specific small-molecule agonists",

abstract = "Human toll-like receptor (hTLR)-8 is expressed in myeloid dendritic cells, monocytes, and monocytederived dendritic cells. Engagement by TLR8 agonists evokes a distinct cytokine profile which favors the development of type 1 helper T cells. Focused exploration of structure-activity relationships in the imidazoquinolines has led to the identification of several novel human TLR8-specific agonists. The synthetic procedures for best-in-class analogues encompassing four chemotypes are described.",

keywords = "Innate immunity, TLR8, TLR8 agonists, Vaccine adjuvants",

author = "Mallesh Beesu and Kokatla, {Hari Prasad} and David, {Sunil A.}",

note = "Funding Information: This work was supported by NIH/NIAID contracts HSN272200900033C and HHSN272201400056C. Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2017.",

year = "2017",

doi = "10.1007/978-1-4939-6445-1_3",

language = "English (US)",

series = "Methods in Molecular Biology",

publisher = "Humana Press Inc.",

pages = "29--44",

booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Syntheses of human TLR8-specific small-molecule agonists

AU - Beesu, Mallesh

AU - Kokatla, Hari Prasad

AU - David, Sunil A.

N1 - Funding Information: This work was supported by NIH/NIAID contracts HSN272200900033C and HHSN272201400056C. Publisher Copyright: © Springer Science+Business Media New York 2017.

PY - 2017

Y1 - 2017

N2 - Human toll-like receptor (hTLR)-8 is expressed in myeloid dendritic cells, monocytes, and monocytederived dendritic cells. Engagement by TLR8 agonists evokes a distinct cytokine profile which favors the development of type 1 helper T cells. Focused exploration of structure-activity relationships in the imidazoquinolines has led to the identification of several novel human TLR8-specific agonists. The synthetic procedures for best-in-class analogues encompassing four chemotypes are described.

AB - Human toll-like receptor (hTLR)-8 is expressed in myeloid dendritic cells, monocytes, and monocytederived dendritic cells. Engagement by TLR8 agonists evokes a distinct cytokine profile which favors the development of type 1 helper T cells. Focused exploration of structure-activity relationships in the imidazoquinolines has led to the identification of several novel human TLR8-specific agonists. The synthetic procedures for best-in-class analogues encompassing four chemotypes are described.

KW - Innate immunity

KW - TLR8

KW - TLR8 agonists

KW - Vaccine adjuvants

UR - http://www.scopus.com/inward/record.url?scp=84991213592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991213592&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-6445-1_3

DO - 10.1007/978-1-4939-6445-1_3

M3 - Chapter

C2 - 27718184

AN - SCOPUS:84991213592

T3 - Methods in Molecular Biology

SP - 29

EP - 44

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -

Syntheses of human TLR8-specific small-molecule agonists

Abstract

Publication series

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this